{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T04:10:27Z","timestamp":1744863027357,"version":"3.40.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Korean Association for the Study of the Liver and The Korean Liver Foundation","award":["2023"],"award-info":[{"award-number":["2023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-025-01729-3","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T13:14:51Z","timestamp":1744809291000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of nucleos(t)ide analogue therapy on the incidence of Alzheimer\u2019s disease in patients with chronic hepatitis B virus infection"],"prefix":"10.1186","volume":"17","author":[{"given":"Jihye","family":"Lim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyundam","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyunji","family":"Sang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su Jin","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ha Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,16]]},"reference":[{"issue":"9","key":"1729_CR1","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","volume":"7","author":"GBDHB Collaborators","year":"2022","unstructured":"Collaborators GBDHB. Global, regional, and National burden of hepatitis B, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet Gastroenterol Hepatol. 2022;7(9):796\u2013829. https:\/\/doi.org\/10.1016\/S2468-1253(22)00124-8.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"1729_CR2","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/s41575-023-00759-2","volume":"20","author":"DQ Huang","year":"2023","unstructured":"Huang DQ, Terrault NA, Tacke F, Gluud LL, Arrese M, Bugianesi E, et al. Global epidemiology of cirrhosis - aetiology, trends and predictions. Nat Rev Gastroenterol Hepatol. 2023;20(6):388\u201398. https:\/\/doi.org\/10.1038\/s41575-023-00759-2.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"1729_CR3","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3350\/cmh.2022.0084","volume":"28","author":"Korean Association for the Study of the L","year":"2022","unstructured":"Korean Association for the Study of the L. KASL clinical practice guidelines for management of chronic hepatitis B. Clin Mol Hepatol. 2022;28(2):276\u2013331. https:\/\/doi.org\/10.3350\/cmh.2022.0084.","journal-title":"Clin Mol Hepatol"},{"issue":"4","key":"1729_CR4","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","volume":"67","author":"NA Terrault","year":"2018","unstructured":"Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560\u201399. https:\/\/doi.org\/10.1002\/hep.29800.","journal-title":"Hepatology"},{"issue":"2","key":"1729_CR5","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","volume":"67","author":"European Association for the Study of the Liver","year":"2017","unstructured":"European Association for the Study of the Liver. Electronic address Eee, European association for the study of the L. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370\u201398. https:\/\/doi.org\/10.1016\/j.jhep.2017.03.021.","journal-title":"J Hepatol"},{"issue":"4","key":"1729_CR6","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3350\/cmh.2022.0420","volume":"29","author":"YC Hsu","year":"2023","unstructured":"Hsu YC, Tseng CH, Kao JH. Safety considerations for withdrawal of nucleos(t)ide analogues in patients with chronic hepatitis B: first, do no harm. Clin Mol Hepatol. 2023;29(4):869\u201390. https:\/\/doi.org\/10.3350\/cmh.2022.0420.","journal-title":"Clin Mol Hepatol"},{"issue":"5","key":"1729_CR7","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1053\/j.gastro.2019.10.050","volume":"158","author":"KS Liem","year":"2020","unstructured":"Liem KS, Gehring AJ, Feld JJ, Janssen HLA. Challenges with stopping Long-term Nucleos(t)ide analogue therapy in patients with chronic hepatitis B. Gastroenterology. 2020;158(5):1185\u201390. https:\/\/doi.org\/10.1053\/j.gastro.2019.10.050.","journal-title":"Gastroenterology"},{"key":"1729_CR8","doi-asserted-by":"publisher","first-page":"204993612098595","DOI":"10.1177\/2049936120985954","volume":"8","author":"L Roade","year":"2021","unstructured":"Roade L, Riveiro-Barciela M, Esteban R, Buti M. Long-term efficacy and safety of nucleos(t)ides analogues in patients with chronic hepatitis B. Ther Adv Infect Dis. 2021;8:2049936120985954. https:\/\/doi.org\/10.1177\/2049936120985954.","journal-title":"Ther Adv Infect Dis"},{"issue":"5","key":"1729_CR9","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s00535-020-01680-0","volume":"55","author":"RS de Fraga","year":"2020","unstructured":"de Fraga RS, Van Vaisberg V, Mendes LCA, Carrilho FJ, Ono SK. Adverse events of nucleos(t)ide analogues for chronic hepatitis B: a systematic review. J Gastroenterol. 2020;55(5):496\u2013514. https:\/\/doi.org\/10.1007\/s00535-020-01680-0.","journal-title":"J Gastroenterol"},{"issue":"5 Suppl","key":"1729_CR10","doi-asserted-by":"publisher","first-page":"S185","DOI":"10.1002\/hep.22885","volume":"49","author":"RJ Fontana","year":"2009","unstructured":"Fontana RJ. Side effects of long-term oral antiviral therapy for hepatitis B. Hepatology. 2009;49(5 Suppl):S185\u201395. https:\/\/doi.org\/10.1002\/hep.22885.","journal-title":"Hepatology"},{"issue":"4","key":"1729_CR11","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jhep.2009.06.011","volume":"51","author":"RD Fleischer","year":"2009","unstructured":"Fleischer RD, Lok AS. Myopathy and neuropathy associated with nucleos(t)ide analog therapy for hepatitis B. J Hepatol. 2009;51(4):787\u201391. https:\/\/doi.org\/10.1016\/j.jhep.2009.06.011.","journal-title":"J Hepatol"},{"issue":"1","key":"1729_CR12","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1038\/s41598-020-58837-3","volume":"10","author":"G Madeddu","year":"2020","unstructured":"Madeddu G, Fiore V, Melis M, Ortu S, Mannu F, Muredda AA, et al. Mitochondrial toxicity and body shape changes during nucleos(t)ide analogues administration in patients with chronic hepatitis B. Sci Rep. 2020;10(1):2014. https:\/\/doi.org\/10.1038\/s41598-020-58837-3.","journal-title":"Sci Rep"},{"key":"1729_CR13","doi-asserted-by":"publisher","first-page":"204020661875852","DOI":"10.1177\/2040206618758524","volume":"26","author":"JY Feng","year":"2018","unstructured":"Feng JY. Addressing the selectivity and toxicity of antiviral nucleosides. Antivir Chem Chemother. 2018;26:2040206618758524. https:\/\/doi.org\/10.1177\/2040206618758524.","journal-title":"Antivir Chem Chemother"},{"issue":"7113","key":"1729_CR14","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nature05292","volume":"443","author":"MT Lin","year":"2006","unstructured":"Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 2006;443(7113):787\u201395. https:\/\/doi.org\/10.1038\/nature05292.","journal-title":"Nature"},{"issue":"Suppl 1","key":"1729_CR15","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/jnc.13731","volume":"139","author":"A Bose","year":"2016","unstructured":"Bose A, Beal MF. Mitochondrial dysfunction in Parkinson\u2019s disease. J Neurochem. 2016;139(Suppl 1):216\u201331. https:\/\/doi.org\/10.1111\/jnc.13731.","journal-title":"J Neurochem"},{"key":"1729_CR16","doi-asserted-by":"publisher","unstructured":"Breijyeh Z, Karaman R. Comprehensive review on Alzheimer\u2019s disease: causes and treatment. Molecules. 2020;25(24). https:\/\/doi.org\/10.3390\/molecules25245789.","DOI":"10.3390\/molecules25245789"},{"key":"1729_CR17","doi-asserted-by":"publisher","first-page":"102068","DOI":"10.1016\/j.arr.2023.102068","volume":"91","author":"F Bruno","year":"2023","unstructured":"Bruno F, Abondio P, Bruno R, Ceraudo L, Paparazzo E, Citrigno L, et al. Alzheimer\u2019s disease as a viral disease: revisiting the infectious hypothesis. Ageing Res Rev. 2023;91:102068. https:\/\/doi.org\/10.1016\/j.arr.2023.102068.","journal-title":"Ageing Res Rev"},{"issue":"11","key":"1729_CR18","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1093\/infdis\/jix506","volume":"216","author":"Y Chang","year":"2017","unstructured":"Chang Y, Choe WH, Sinn DH, Lee JH, Ahn SH, Lee H, et al. Nucleos(t)ide analogue treatment for patients with hepatitis B virus (HBV) e Antigen-Positive chronic HBV genotype C infection: A nationwide, multicenter, retrospective study. J Infect Dis. 2017;216(11):1407\u201314. https:\/\/doi.org\/10.1093\/infdis\/jix506.","journal-title":"J Infect Dis"},{"issue":"10284","key":"1729_CR19","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chetelat G, Teunissen CE, et al. Alzheimer\u2019s disease. Lancet. 2021;397(10284):1577\u201390. https:\/\/doi.org\/10.1016\/S0140-6736(20)32205-4.","journal-title":"Lancet"},{"key":"1729_CR20","doi-asserted-by":"publisher","unstructured":"Felipo V, Montoliu C, Llansola M. Neuroinflammation and neurological alterations in chronic liver diseases. Neuroimmunol Neuroinflammation. 2015;2(3). https:\/\/doi.org\/10.4103\/2347-8659.160845.","DOI":"10.4103\/2347-8659.160845"},{"key":"1729_CR21","doi-asserted-by":"publisher","first-page":"805625","DOI":"10.3389\/fmolb.2021.805625","volume":"8","author":"S Zhong","year":"2021","unstructured":"Zhong S, Zhang T, Tang L, Li Y. Cytokines and chemokines in HBV infection. Front Mol Biosci. 2021;8:805625. https:\/\/doi.org\/10.3389\/fmolb.2021.805625.","journal-title":"Front Mol Biosci"},{"key":"1729_CR22","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3389\/fnagi.2019.00174","volume":"11","author":"LD Estrada","year":"2019","unstructured":"Estrada LD, Ahumada P, Cabrera D, Arab JP. Liver dysfunction as a novel player in Alzheimer\u2019s progression: looking outside the brain. Front Aging Neurosci. 2019;11:174. https:\/\/doi.org\/10.3389\/fnagi.2019.00174.","journal-title":"Front Aging Neurosci"},{"key":"1729_CR23","unstructured":"service Nhi. 2023 national health insurance and long-term insurance system in republic of Korea. 2023."},{"key":"1729_CR24","doi-asserted-by":"publisher","DOI":"10.12997\/jla.2022.11.2.103","author":"DS Kyoung","year":"2022","unstructured":"Kyoung DS, Kim HS. Understanding and Utilizing Claim Data from the Korean National Health Insurance Service (NHIS) and Health Insurance Review & Assessment (HIRA) Database for Research. J Lipid Atheroscler. 2022;11(2):103-10. doi: 10.12997\/jla.2022.11.2.103. https:\/\/doi.org\/10.12997\/jla.2022.11.2.103"},{"key":"1729_CR25","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000002354","author":"J Lim","year":"2023","unstructured":"Lim J, Kim YJ, Kim S, Choi J. Increased risk of osteoporotic fracture in patients with autoimmune hepatitis. Am J Gastroenterol. 2023. https:\/\/doi.org\/10.14309\/ajg.0000000000002354.","journal-title":"Am J Gastroenterol"},{"key":"1729_CR26","doi-asserted-by":"publisher","first-page":"883549","DOI":"10.3389\/fneur.2022.883549","volume":"13","author":"MS Baek","year":"2022","unstructured":"Baek MS, Kim HK, Han K, Kwon HS, Na HK, Lyoo CH, et al. Annual trends in the incidence and prevalence of Alzheimer\u2019s disease in South Korea: A nationwide cohort study. Front Neurol. 2022;13:883549. https:\/\/doi.org\/10.3389\/fneur.2022.883549.","journal-title":"Front Neurol"},{"key":"1729_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-7568(24)00112-0","author":"JH Heo","year":"2024","unstructured":"Heo JH, Jung HN, Roh E, Han KD, Kang JG, Lee SJ, et al. Association of remnant cholesterol with risk of dementia: a nationwide population-based cohort study in South Korea. Lancet Healthy Longev. 2024. https:\/\/doi.org\/10.1016\/S2666-7568(24)00112-0.","journal-title":"Lancet Healthy Longev"},{"issue":"4","key":"1729_CR28","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41582-024-00940-4","volume":"20","author":"AD Korczyn","year":"2024","unstructured":"Korczyn AD, Grinberg LT. Is alzheimer disease a disease? Nat Rev Neurol. 2024;20(4):245\u201351. https:\/\/doi.org\/10.1038\/s41582-024-00940-4.","journal-title":"Nat Rev Neurol"},{"issue":"446","key":"1729_CR29","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496\u2013509. https:\/\/doi.org\/10.1080\/01621459.1999.10474144.","journal-title":"J Am Stat Assoc"},{"issue":"5","key":"1729_CR30","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1111\/liv.15244","volume":"42","author":"GA Kim","year":"2022","unstructured":"Kim GA, Oh CH, Kim JW, Jeong SJ, Oh IH, Lee JS, et al. Association between non-alcoholic fatty liver disease and the risk of dementia: A nationwide cohort study. Liver Int. 2022;42(5):1027\u201336. https:\/\/doi.org\/10.1111\/liv.15244.","journal-title":"Liver Int"},{"issue":"2","key":"1729_CR31","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1093\/biostatistics\/kxs043","volume":"14","author":"EP Wileyto","year":"2013","unstructured":"Wileyto EP, Li Y, Chen J, Heitjan DF. Assessing the fit of parametric cure models. Biostatistics. 2013;14(2):340\u201350. https:\/\/doi.org\/10.1093\/biostatistics\/kxs043.","journal-title":"Biostatistics"},{"issue":"22","key":"1729_CR32","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1200\/JCO.2014.55.2208","volume":"32","author":"H Uno","year":"2014","unstructured":"Uno H, Claggett B, Tian L, Inoue E, Gallo P, Miyata T, et al. Moving beyond the hazard ratio in quantifying the between-group difference in survival analysis. J Clin Oncol. 2014;32(22):2380\u20135. https:\/\/doi.org\/10.1200\/JCO.2014.55.2208.","journal-title":"J Clin Oncol"},{"key":"1729_CR33","doi-asserted-by":"publisher","first-page":"3934901","DOI":"10.1155\/2022\/3934901","volume":"2022","author":"Q Huang","year":"2022","unstructured":"Huang Q, Tian C. Visualizing Time-Varying effect in survival analysis: 5 complementary plots to Kaplan-Meier curve. Oxid Med Cell Longev. 2022;2022:3934901. https:\/\/doi.org\/10.1155\/2022\/3934901.","journal-title":"Oxid Med Cell Longev"},{"issue":"5","key":"1729_CR34","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.jagp.2023.12.011","volume":"32","author":"MH Tao","year":"2024","unstructured":"Tao MH, Gordon SC, Wu T, Trudeau S, Rupp LB, Gonzalez HC, et al. Antiviral treatment and response are associated with lower risk of dementia among hepatitis C Virus-Infected patients. Am J Geriatr Psychiatry. 2024;32(5):611\u201321. https:\/\/doi.org\/10.1016\/j.jagp.2023.12.011.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"1","key":"1729_CR35","doi-asserted-by":"publisher","first-page":"e85637","DOI":"10.1371\/journal.pone.0085637","volume":"9","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Song F, Gao Z, Ding W, Qiao L, Yang S, et al. Long-term exposure of mice to nucleoside analogues disrupts mitochondrial DNA maintenance in cortical neurons. PLoS ONE. 2014;9(1):e85637. https:\/\/doi.org\/10.1371\/journal.pone.0085637.","journal-title":"PLoS ONE"},{"issue":"8","key":"1729_CR36","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1111\/ene.12317","volume":"21","author":"WC Chiu","year":"2014","unstructured":"Chiu WC, Tsan YT, Tsai SL, Chang CJ, Wang JD, Chen PC, et al. Hepatitis C viral infection and the risk of dementia. Eur J Neurol. 2014;21(8):1068\u2013e59. https:\/\/doi.org\/10.1111\/ene.12317.","journal-title":"Eur J Neurol"},{"issue":"29","key":"1729_CR37","doi-asserted-by":"publisher","first-page":"e26476","DOI":"10.1097\/MD.0000000000026476","volume":"100","author":"HG Choi","year":"2021","unstructured":"Choi HG, Soh JS, Lim JS, Sim SY, Lee SW. Association between dementia and hepatitis B and C virus infection. Med (Baltim). 2021;100(29):e26476. https:\/\/doi.org\/10.1097\/MD.0000000000026476.","journal-title":"Med (Baltim)"},{"issue":"1","key":"1729_CR38","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3350\/cmh.2016.22.1.76","volume":"22","author":"Korean Association for the Study of the L","year":"2016","unstructured":"Korean Association for the Study of the L. KASL clinical practice guidelines: management of hepatitis C. Clin Mol Hepatol. 2016;22(1):76\u2013139. https:\/\/doi.org\/10.3350\/cmh.2016.22.1.76.","journal-title":"Clin Mol Hepatol"},{"issue":"5","key":"1729_CR39","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1136\/gutjnl-2017-314904","volume":"67","author":"GA Kim","year":"2018","unstructured":"Kim GA, Lim YS, Han S, Choi J, Shim JH, Kim KM, et al. High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B. Gut. 2018;67(5):945\u201352. https:\/\/doi.org\/10.1136\/gutjnl-2017-314904.","journal-title":"Gut"},{"issue":"1","key":"1729_CR40","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12876-024-03208-9","volume":"24","author":"S Wei","year":"2024","unstructured":"Wei S, Xie Q, Liao G, Chen H, Hu M, Lin X, et al. Patients with chronic hepatitis B who have persistently normal Alanine aminotransferase or aged\u2009<\u200930 years May exhibit significant histologic damage. BMC Gastroenterol. 2024;24(1):120. https:\/\/doi.org\/10.1186\/s12876-024-03208-9.","journal-title":"BMC Gastroenterol"},{"issue":"5","key":"1729_CR41","doi-asserted-by":"publisher","first-page":"e0177044","DOI":"10.1371\/journal.pone.0177044","volume":"12","author":"ML Haaksma","year":"2017","unstructured":"Haaksma ML, Vilela LR, Marengoni A, Calderon-Larranaga A, Leoutsakos JS, Olde Rikkert MGM, et al. Comorbidity and progression of late onset Alzheimer\u2019s disease: A systematic review. PLoS ONE. 2017;12(5):e0177044. https:\/\/doi.org\/10.1371\/journal.pone.0177044.","journal-title":"PLoS ONE"},{"key":"1729_CR42","doi-asserted-by":"publisher","first-page":"631770","DOI":"10.3389\/fnagi.2021.631770","volume":"13","author":"JA Santiago","year":"2021","unstructured":"Santiago JA, Potashkin JA. The impact of disease comorbidities in Alzheimer\u2019s disease. Front Aging Neurosci. 2021;13:631770. https:\/\/doi.org\/10.3389\/fnagi.2021.631770.","journal-title":"Front Aging Neurosci"},{"issue":"8","key":"1729_CR43","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.neuron.2024.01.024","volume":"112","author":"C Lopez-Lee","year":"2024","unstructured":"Lopez-Lee C, Torres ERS, Carling G, Gan L. Mechanisms of sex differences in Alzheimer\u2019s disease. Neuron. 2024;112(8):1208\u201321. https:\/\/doi.org\/10.1016\/j.neuron.2024.01.024.","journal-title":"Neuron"},{"issue":"8","key":"1729_CR44","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41582-018-0032-9","volume":"14","author":"MT Ferretti","year":"2018","unstructured":"Ferretti MT, Iulita MF, Cavedo E, Chiesa PA, Schumacher Dimech A, Santuccione Chadha A, et al. Sex differences in alzheimer disease - the gateway to precision medicine. Nat Rev Neurol. 2018;14(8):457\u201369. https:\/\/doi.org\/10.1038\/s41582-018-0032-9.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"1729_CR45","doi-asserted-by":"publisher","first-page":"e2353965","DOI":"10.1001\/jamanetworkopen.2023.53965","volume":"7","author":"JS Bajaj","year":"2024","unstructured":"Bajaj JS, Silvey SG, Rogal S, O\u2019Leary JG, Patton H, Morgan TR, et al. Undiagnosed cirrhosis and hepatic encephalopathy in a National cohort of veterans with dementia. JAMA Netw Open. 2024;7(1):e2353965. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.53965.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"1729_CR46","doi-asserted-by":"publisher","first-page":"475","DOI":"10.14309\/ajg.0000000000002189","volume":"118","author":"A Adejumo","year":"2023","unstructured":"Adejumo A, Noll A, Rogal SS, Yakovchenko V, Chia L, Spoutz P, et al. Dementia frequently coexists with hepatic encephalopathy but not other cirrhosis complications in US veterans. Am J Gastroenterol. 2023;118(3):475\u201380. https:\/\/doi.org\/10.14309\/ajg.0000000000002189.","journal-title":"Am J Gastroenterol"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01729-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01729-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01729-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T13:14:56Z","timestamp":1744809296000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-025-01729-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,16]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1729"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01729-3","relation":{"references":[{"id-type":"doi","id":"10.12997\/jla.2022.11.2.103","asserted-by":"subject"}]},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,16]]},"assertion":[{"value":"28 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Hanyang University Guri Hospital (IRB No. 2023-04-039). The need for informed consent was waived due to the usage of de-identified data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"84"}}